EiRx buys stake in Auvation
The company said it has bought a 56% stake in Scottish biotechnology firm Auvation. The company develops ways to diagnose and treat cancer.
EiRx said in the year to end August 2003, Auvation had profits of E114,003 and assets of E121,214. All the company’s revenues have been reinvested in development of its technology, workforce and facilities, it added.
Read
Listen
Watch
Play
CONNECT WITH US TODAY
Be the first to know the latest news and updates
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.
Business
Push Notifications
By clicking on sign up you will be the first to know about a selection of business content on this browser. Please note if you are unable to sign up via your mobile web browser, download and sign up for mobile push notifications via our FREE news app.
Sign Up
The Business Hub
Newsletter
News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.
Lunchtime News
Newsletter
Get a lunch briefing straight to your inbox at noon daily. Also be the first to know with our occasional Breaking News emails.
Most Read
Saturday, May 9, 2026 - 7:00 PM
Saturday, May 9, 2026 - 8:00 PM
Saturday, May 9, 2026 - 8:00 PM
